SGLT2 inhibitors

Enhance your knowledge with the first 3 programmes in this series, providing concise evidence-based guidance to contemporary medications and their application in daily care with the aim of assessing the clinical evidence and opportunities offered by sodium-glucose co-transporter-2 (SGLT2) inhibitors in the management of type 2 diabetes and its cardio-renal complications.

SGLT2 (1/3): Understanding SGLT2 inhibition

What do we need to know about Type 2 diabetes and SGLT2 inhibitors and how do they control glycaemia and body weight

SGLT2 (2/3): SGLT2 inhibitors and the heart

The effects of SGLT2 inhibitors on cardiovascular (CV) function and their role in the management of CV disease

SGLT2 (3/3): SGLT2 inhibitors and the kidney

The reno-protective effects of SGLT2 inhibitors in the management diabetic kidney disease

View all CPD

Educational Partners